All Pharmaceuticals articles – Page 7
-
Article
Eli Lilly adds general counsel
Pharmaceuticals firm Eli Lilly and Company announced Anat Hakim will join the company as senior vice-president and general counsel.
-
Article
Teva to pay $54M in FCA whistleblower settlement
Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers over allegations the drug company bribed physicians through numerous “sham” speaker programs in exchange for prescribing Teva drugs.
-
Premium
Top ethics and compliance failures of 2019
From antitrust and privacy concerns in the tech world to compliance officer liability in the pharmaceutical industry to unethical practices in the banking and accounting professions, more than a dozen companies made Compliance Week’s list of the biggest compliance fails in 2019.
-
Article
ICO hands out first GDPR fine as BA, Marriott cases linger
The U.K. Information Commissioner’s Office has levied its first fine under the GDPR against a London-based pharmacy. Record-setting penalties announced by the ICO in July against British Airways and Marriott are still not finalized.
-
Article
Alleged compliance failures at Omnicare lead to healthcare fraud lawsuit
A series of alleged compliance failures at pharmaceutical services provider Omnicare has resulted in the Department of Justice intervening in yet another civil healthcare fraud lawsuit against the company.
-
Article
Signant Health appoints chief compliance officer
Pharmaceutical technology firm Signant Health announced the appointment of Paul Drake as chief compliance and security officer.
-
Article
Roche veteran general counsel to retire
Swiss pharmaceutical firm Roche announced Gottlieb Keller will retire as general counsel at the end of March 2020. Keller’s career at Roche spanned 35 years.
-
Article
BioPlus Specialty Pharmacy hires chief compliance and privacy officer
BioPlus Specialty Pharmacy has named Brian Cherico as its chief compliance and privacy officer.
-
Article
Former Herbalife execs charged with FCPA violations
The DOJ has charged two former executives of Herbalife with violations of the Foreign Corrupt Practices Act for bribing Chinese government officials for over a decade and then trying to cover up the illicit payments.
-
Article
Labeling employee a ‘compliance risk’ not defamation, says court
A former Biomet Argentina employee—in a bit of FCPA hot water—landed on his company’s restricted persons list, sued for defamation, and lost.
-
Article
Aerie Pharmaceuticals appoints chief compliance officer
Aerie Pharmaceuticals has appointed Charlene Davis as vice president and chief compliance officer.
-
Article
Q&A: Shaping culture for the greater good at AstraZeneca
In this one-on-one, we caught up with Louise Vamvoukaki, director of sustainability education and engagement at AstraZeneca, who shared how the company overhauled its organizational culture through design of its Code of Ethics.
-
Article
Avanir to pay $116M for engaging in kickback scheme
Avanir Pharmaceuticals will pay a combined $116 million in civil and criminal penalties for paying kickbacks to a physician to induce prescriptions of its drug Nuedexta, the Department of Justice announced.
-
Article
Mylan finalizes $30M EpiPen settlement with SEC
Mylan has finalized a previously disclosed $30 million settlement with the SEC for alleged accounting and disclosure failures surrounding its popular EpiPen.
-
Article
Mallinckrodt to pay $15.4M over kickback allegations
Pharmaceutical company Mallinckrodt is set to pay $15.4 million to the Justice Department to resolve allegations of illegal kickbacks to doctors in the form of lavish dinners and entertainment.
-
Article
Kadmon appoints general counsel, chief compliance officer
Kadmon Holdings announced the appointment of Gregory Moss as executive vice president, general counsel, and corporate secretary. Moss will also serve as chief compliance officer.
-
Article
Jaguar Health appoints chief accounting officer
Jaguar Health announced the promotion of Carol Lizak to chief accounting officer. Lizak formerly served as Jaguar’s vice president of finance and corporate controller.
-
Article
TherapeuticsMD to pay $200K for Reg FD violations
Pharmaceutical company TherapeuticsMD agreed to pay a $200,000 penalty to resolve charges brought by the SEC for Reg FD violations. The case imparts some compliance lessons.
-
Article
Aspen to pay $9.7M to settle U.K. competition concerns
Aspen Pharmacare has offered to pay the U.K.’s National Health Service £8 million (U.S. $9.7 million) following suspicions that the company paid rival firms to delay marketing a vital medicine to retain market dominance.
-
Article
Chief compliance officer liability and the opioid epidemic
In a period of three months, two chief compliance officers have been charged for their individual roles in the opioid epidemic—a clear indication the Department of Justice continues to expand the scope of prosecutions to those who fail in their compliance responsibilities.